Loading insider details...
Beta
Latest Form 4 (Oct 19, 2026): Sale of 7,066 RARE shares, $107.9K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 19, 2026 | Ultragenyx Pharmaceutical Inc. (RARE) | Sale | 7,066 | $107.9K |
| Aug 4, 2026 | Ultragenyx Pharmaceutical Inc. (RARE) | Sale | 4,696 | $117.0K |
| Jul 6, 2026 | Ultragenyx Pharmaceutical Inc. (RARE) | Sale | 4,698 | $155.6K |
| Jun 1, 2026 | Ultragenyx Pharmaceutical Inc. (RARE) | Sale | 4,653 | $110.6K |
| May 4, 2026 | Ultragenyx Pharmaceutical Inc. (RARE) | Sale | 4,683 | $116.6K |
| Apr 20, 2026 | Ultragenyx Pharmaceutical Inc. (RARE) | Grant/Award | 34,674 | n/a |
| Apr 2, 2026 | Ultragenyx Pharmaceutical Inc. (RARE) | Sale | 4,683 | $98.2K |
| Mar 3, 2026 | Ultragenyx Pharmaceutical Inc. (RARE) | Grant/Award | 6,143 | n/a |
| Feb 3, 2026 | Ultragenyx Pharmaceutical Inc. (RARE) | Sale | 3,061 | $72.1K |
| Jan 5, 2026 | Ultragenyx Pharmaceutical Inc. (RARE) | Sale | 3,150 | $71.9K |